Press release
Lung Cancer Therapeutics Market 2018 Global Analysis,Research,Review,Applications and Forecast to 2023
WiseGuyReports.Com adds “Lung Cancer Therapeutics Market 2018 Global Analysis,Research,Review,Applications and Forecast to 2023” Research to its Database.Description:
Lung cancer or lung carcinoma is the disease characterized by the abnormal proliferation of tumour cells in the lung tissues. Lung cancer is classified into 3 types namely lung carcinoid tumour, small cell lung cancer, and non-small cell lung cell cancer. Common symptoms associated with the lung cancer include a cough, weight loss, shortness of breath, and chest pains. Smoking and prolonged use of tobacco are the common risk factors for the lung cancer. Lung cancer can be diagnosed by the biopsy performed by using CT-guidance or bronchoscopy. Lung cancer can be treated by radiotherapy, chemotherapy, and surgery.
Increasing pollution owing to rapid industrialization, a rise in the number of tobacco consumption and smoking population, growing government funding for the R&D activities, and rise in demand for targeted therapies are anticipated to fuel the growth of lung cancer therapeutics market. Moreover, innovation of newer radiotherapies, a launch of low priced generic drugs, and rise in prevalence of non-small cell lung cancer are expected to propel the lung cancer therapeutics market over the forecast period. However, stringent regulatory policies, patent expiry of lung cancer therapeutics, poor cancer diagnostics in underdeveloped countries, and adverse effects associated with the treatment might hamper the growth of lung cancer therapeutics market.
Get a Sample Report @ https://www.wiseguyreports.com/sample-request/2753929-lung-cancer-therapeutics-market-2012-to-2023
For more information or any query mail at sales@wiseguyreports.com
Lung cancer therapeutics market segmented based on the treatment type, disease type, and end user
Based on the drug type, lung cancer therapeutics market segmented into the following:
Chemotherapy
Taxol
Navelbine
Alimta
Cisplatin
Camptosar
Others
Targeted therapy
Gilotrif
Tarceva
Avastin
Iressa
Others
Based on the disease type, lung cancer therapeutics market segmented into the following:
Small cell lung cancer
Non-small cell lung cancer
Large carcinoid tumour
Based on the end user, lung cancer therapeutics market segmented into the following:
Hospitals
Oncology Clinics
Ambulatory surgical centres
Global lung cancer therapeutics market is growing at a significant CAGR over the forecast timeframe owing to increase in the R&D activities clinical trials for the innovation of new drugs and vaccines for the treatment of lung cancer. Increase in the prevalence of lung cancer (according to world cancer research fund international 2012, lung cancer was the most common cancer which contributes 13% share of the new cancer cases diagnosed) also propelling the lung cancer therapeutics market. Acquisitions & mergers, collaborations are the key strategies adopted by the players to gain revenue growth in lung cancer therapeutics market. For instance, in November 2015, Eli Lilly and Co. and Merck & Co., Inc. collaborated to evaluate the efficacy and safety of a combination of the Alimta and Keytruda under phase III trials for the treatment of non-small cell lung cancer. Moreover, in January 2016, VisionGate acquired a patent from University of Colorado for Iloprost used in the treatment of lung cancer. Similarly, In September 2014, Asterias Biotherapeutics collaborated with Cancer Research UK for the development of a vaccine for the treatment of non-small cell lung cancer.
Geographically, Lung cancer therapeutics market is segmented into the Europe, Latin America, Asia Pacific, Middle East and Africa, and North America. North America lung cancer therapeutics market is growing due to increase in the prevalence of lung cancer majorly in U.S. (according to CDC 2014, about 215,951 people diagnosed with lung cancer and 155,526 people died of the lung cancer). In addition, increase the funding for the R&D activities, and early diagnosis of the disease is expected to propel the lung cancer therapeutics market in North America. In Europe region, rise in the prevalence of lung cancer majorly in Hungary, Serbia, U.K and other Europe countries (according to Cancer Research UK, about 46,403 new lung cancer in the UK and 35,895 people died of the disease), rise in the government funding for lung cancer R&D activities, and advanced healthcare infrastructure are boosting the lung cancer therapeutics market. Asia Pacific region is exhibiting significant growth in lung cancer therapeutics market owing to rapid industrialization and availability of low-cost generic products in the region.
Some of the players in lung cancer therapeutics market are Eli Lilly and Company (U.S.), GlaxoSmithKline Plc (U.K.), AstraZeneca (U.S.), Pfizer, Inc. (U.S.), F. Hoffmann-La Roche Ltd. (Switzerland), Merck & Co. Inc. (U.S.), Boehringer Ingelheim GmbH (Germany), Novartis AG (Switzerland), Takeda Pharmaceuticals Co. Ltd. (Japan), Abbvie, Inc. (U.S.), VisionGate, Inc. (U.S.), and Asterias Biotherapeutics (Biotime) (U.S.) to name a few.
In April 2017, Takeda Pharmaceutical received an approval from FDA for Alunbrig (brigatinib) used in the treatment of ALK+ non-small cell lung cancer
In April 2017, AstraZeneca received approval from European Commission for the marketing authorization of Tagrisso used in the treatment of non-small cell lung cancer
Ask Query @ https://www.wiseguyreports.com/enquiry/2753929-lung-cancer-therapeutics-market-2012-to-2023
Table Of Contents – Major Key Points
1. Executive summary
2. Global Lung Cancer Therapeutics Market Introduction
2.1. Global Lung Cancer Therapeutics Market – Taxonomy
2.2. Global Lung Cancer Therapeutics Market –Definitions
2.2.1. Drug class
2.2.2. Distribution Channel
3. Global Lung Cancer Therapeutics Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Global Lung Cancer Therapeutics Market Dynamics – Factors Impact Analysis
3.6. Global Lung Cancer Therapeutics Market – Regulations
3.6.1. U.S
3.6.2. Europe
3.6.3. Japan
3.6.4. China
3.7. Global Lung Cancer Therapeutics Market – Pipeline Analysis
4. Global Lung Cancer Therapeutics Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023
4.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
4.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
4.3. Market Oppurtunity Analysis
5. Global Lung Cancer Therapeutics Market, By Drug Class, 2012 - 2016 and Forecast, 2017 - 2023
5.1. Drug Class Analysis (2012-2016) and Forecast (2017-2023) by Revenue (USD Mn) and Y-o-Y Growth (%)
5.1.1. Chemotherapy
5.1.1.1. Taxol
5.1.1.2. Navelbine
5.1.1.3. Alimta
5.1.1.4. Cisplatin
5.1.1.5. Camptosar
5.1.1.6. Others
5.1.2. Targeted therapy
5.1.2.1. Gilotrif
5.1.2.2. Tarceva
5.1.2.3. Avastin
5.1.2.4. Iressa
5.1.2.5. Others
5.1.3. Market Opportunity Analysis
6. Global Lung Cancer Therapeutics Market Forecast, By Disease Type, 2012 - 2016 and Forecast, 2017 - 2023
6.1. Small Cell Lung Cancer
6.1.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
6.1.3. Market Opportunity Analysis
6.2. Non-Small Cell Lung Cancer
6.2.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
6.2.3. Market Opportunity Analysis
6.3. Large Carcinoid Tumor
6.3.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
6.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
7. Market Opportunity Analysis Global Lung Cancer Therapeutics Market Forecast, By End User, 2012 - 2016 and Forecast, 2017 - 2023
7.1. Hospitals
7.1.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
7.1.3. Market Opportunity Analysis
7.2. Oncology Clinics
7.2.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
7.2.3. Market Opportunity Analysis
7.3. Ambulatory Surgical Centers
7.3.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
7.3.3. Market Opportunity Analysis
Continue…….
Buy 1-User PDF @ https://www.wiseguyreports.com/checkout?currency=one_user-USD&report_id=2753929
For more information or any query mail at sales@wiseguyreports.com
ABOUT US:
Wise Guy Reports is part of the Wise Guy Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe. Wise Guy Reports features an exhaustive list of market research reports from hundreds of publishers worldwide. We boast a database spanning virtually every market category and an even more comprehensive collection of market research reports under these categories and sub-categories.
Office No.528,Amanora Chambers,Magarpatta Road,Hadapsar,Pune-411028.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Lung Cancer Therapeutics Market 2018 Global Analysis,Research,Review,Applications and Forecast to 2023 here
News-ID: 896356 • Views: …
More Releases from WiseGuy Research Consultants Pvt. Ltd.

Surveillance 2018 Global Market Net Worth US$ 43600 million Forecast By 2022
WiseGuyReports.Com Publish a New Market Research Report On –“ Surveillance 2018 Global Market Net Worth US$ 43600 million Forecast By 2022”.
Description:
The Surveillance industry has also suffered a certain impact, but still maintained a relatively optimistic growth, the past four years, Surveillance market size to maintain the average annual growth rate of 11.54% from 17980 million $ in 2014 to 24950 million $ in 2017, The analysts believe that in the…

Tunnel Boring Machine (TBM) Market 2018 Global Analysis By Key Players – Herre …
WiseGuyReports.Com Publish a New Market Research Report On –“ Tunnel Boring Machine (TBM) Market 2018 Global Analysis By Key Players – Herrenknecht, CRTG, CRCHI, Robbins, Tianhe, Komatsu, Mitsubishi”.
Description:
The Tunnel Boring Machine (TBM) industry has also suffered a certain impact, but still maintained a relatively optimistic growth, the past four years, Tunnel Boring Machine (TBM) market size to maintain the average annual growth rate of 7.11% from 1880 million $ in…

Ultra Fine Copper Powder 2018 Global Market Net Worth US$ 405 million Forecast B …
WiseGuyReports.Com Publish a New Market Research Report On –“ Ultra Fine Copper Powder 2018 Global Market Net Worth US$ 405 million Forecast By 2022”.
Description:
The Ultra Fine Copper Powder industry has also suffered a certain impact, but still maintained a relatively optimistic growth, the past four years, Ultra Fine Copper Powder market size to maintain the average annual growth rate of 5.27% from 270 million $ in 2014 to 315 million…

Car Leasing Market 2018 Global Share,Trend,Segmentation and Forecast to 2022
WiseGuyReports.Com Publish a New Market Research Report On –“ Car Leasing Market 2018 Global Share,Trend,Segmentation and Forecast to 2022”.
Description:
The Car Leasing industry has also suffered a certain impact, but still maintained a relatively optimistic growth, the past four years, Car Leasing market size to maintain the average annual growth rate of X% from XXXX million $ in 2013 to XXXX million $ in 2016, The analysts believe that in the…
More Releases for Lung
Lung Cancer Prevalence Driving The Lung Cancer Drugs Market: Core Growth Enabler …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Will the Lung Cancer Drugs Industry Market Size Be by 2025?
The market for lung cancer medications has seen a swift expansion in previous years. The market size is projected to escalate from $47.94 billion in 2024 to $54.13 billion in 2025, with a compound annual growth rate…
Lung Cancer Prevalence Driving The Lung Cancer Drugs Market: An Emerging Driver …
The Lending And Payments Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Projected Growth of the Lending And Payments Market?
The lending and payments market has experienced strong growth in recent years. It is set to rise from $12,326.44 billion in 2024 to…
Transforming the Lung Cancer Drugs Market in 2025: Lung Cancer Prevalence Drivin …
What Is the Expected Size and Growth Rate of the Lung Cancer Drugs Market?
The market size for lung cancer medications has seen swift expansion in the recent past. Its growth is projected to surge from $47.94 billion in 2024 to $54.13 billion in 2025, marking a compound annual growth rate (CAGR) of 12.9%. Factors contributing to the historical period's growth include epidemiology and demographics, regulatory authorizations, healthcare system infrastructure, and…
Transforming the Lung Cancer Drugs Market in 2025: Lung Cancer Prevalence Drivin …
What Is the Expected Size and Growth Rate of the Lung Cancer Drugs Market?
The market size for lung cancer medications has seen swift expansion in the recent past. Its growth is projected to surge from $47.94 billion in 2024 to $54.13 billion in 2025, marking a compound annual growth rate (CAGR) of 12.9%. Factors contributing to the historical period's growth include epidemiology and demographics, regulatory authorizations, healthcare system infrastructure, and…
Lung Cancer Screening Market - Empowering Proactive Lung Health: The Future of C …
Newark, New Castle, USA: The "Lung Cancer Screening Market" provides a value chain analysis of revenue for the anticipated period from 2022 to 2030. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors
Lung Cancer Screening Market: https://www.growthplusreports.com/report/lung-cancer-screening-market/7787
This latest report researches the industry structure,…
Artificial Lung Market May Set New Growth Story | Breethe, Lung Biotechnology, M …
A new research document is added in HTF MI database of 37 pages, titled as 'Artificial Lung - Medical Devices Pipeline Assessment, 2020' with detailed analysis, Competitive landscape, forecast and strategies. The study covers important players/vendors such as ALung Technologies Inc, Breethe, Inc., Case Western Reserve University, Lung Biotechnology PBC, MC3 Inc, McGowan Institute for Regenerative , Medicine, Miromatrix Medical Inc, The Charles Stark Draper Laboratory Inc, U.S. Ann Arbor…